Sareum Holdings plc (LON:SAR – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 21.57 ($0.27) and traded as high as GBX 25.25 ($0.32). Sareum shares last traded at GBX 24.25 ($0.30), with a volume of 148,154 shares.
Sareum Trading Up 0.5 %
The company has a market cap of £26.04 million, a price-to-earnings ratio of -404.17 and a beta of -0.79. The firm has a 50-day moving average price of GBX 21.57 and a 200 day moving average price of GBX 43.05.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Read More
- Five stocks we like better than Sareum
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What Investors Need to Know to Beat the Market
- Generac Powers Ahead on the Electrification Mega-Trend
- Compound Interest and Why It Matters When Investing
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
